Ambulatory Surgical Centers Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

The global ambulatory surgical centers market was valued at USD 108.67 Billion in 2025. It is poised to grow at a CAGR of 4.60% during the forecast period of 2026-2035, and reach USD 170.38 Billion by 2035. The market growth is driven by the rising prevalence of chronic diseases requiring surgical intervention, increasing geriatric population, and the growing demand for cost-effective outpatient procedures.

Q1 2026 Market Updates

Geopolitical Impact of Iran, US, and Israel War on the Ambulatory Surgical Centers Market

United States: The Ambulatory Surgical Centers Market, a key segment of the global economy, is experiencing a complex operating environment in Q1 2026 as a direct consequence of the US-Israel-Iran war. Petrochemical-derived pharmaceutical packaging materials including blister packs, polymer bottles, and specialty film coatings are facing 15-20% cost inflation from the Gulf supply disruption. API production costs are rising as petrochemical reagent prices increase 15-20%. Air freight costs have spiked dramatically, with temperature-sensitive pharmaceutical distribution facing elevated costs and extended lead times as Gulf carrier networks remain suspended. Consumer spending caution is growing as gasoline above USD 4 per gallon and 4.2% projected inflation compress household discretionary budgets. Clinical trial operations in Middle Eastern investigator sites have been disrupted, and medical supply chains face elevated logistics costs.

Iran: Iran's healthcare system has been severely damaged by the conflict, with the WHO identifying at least 13 health facilities as conflict-damaged. The domestic pharmaceutical and medical device sector, already severely constrained by sanctions limiting access to Western medical technology and APIs, has been further disrupted by power outages, workforce displacement, and the collapse of medical supply chain logistics. Iranian patients requiring treatment for ambulatory surgical centers conditions face an acute access crisis, as hospital operations are redirected toward treating conflict casualties and basic medical supplies are running low.

Israel: Israel's pharmaceutical and medical device sector is operating under emergency conditions. Israeli hospitals have moved some operations underground, medical resources are being prioritised for conflict casualties, and elective and non-emergency healthcare consumption has declined. However, Israel's biopharmaceutical research base continues to operate, with several Israeli companies involved in novel treatment development for ambulatory surgical centers indications. Post-conflict, Israel's healthcare system is expected to invest significantly in medical technology and pharmaceutical infrastructure restoration and capacity expansion.

Key Takeaways

Government

• Relevant health authorities should activate emergency pharmaceutical supply chain resilience protocols, ensuring that API and packaging material sourcing for essential ambulatory surgical centers treatments is not concentrated in Gulf-adjacent supply chains exposed to maritime disruption.
• Regulatory agencies should fast-track review of treatment availability and consider emergency compassionate use extensions for patients in conflict-affected regions who face interruption to their standard of care.
• Governments should monitor petrochemical-derived pharmaceutical packaging cost inflation, ensuring that price increases remain within access thresholds for patients requiring ongoing ambulatory surgical centers treatment.

Market

• Petrochemical-derived pharmaceutical packaging and API precursor costs are rising 15-20%, creating margin compression for ambulatory surgical centers manufacturers in the near term, with limited ability to pass costs through in price-regulated markets.
• The conflict's disruption to clinical trial infrastructure in Middle Eastern sites may modestly delay regulatory submissions and new treatment launches that had enrolled patients from the region, though the structural market growth trajectory remains intact.
• Healthcare system demand for ambulatory surgical centers treatment is fundamentally driven by disease burden and demographics rather than geopolitical events, providing strong structural insulation for the market's long-term growth trajectory.

Procurement

• Pharmaceutical procurement teams should build 90-day safety stock for essential ambulatory surgical centers treatment drugs and biological agents, hedging against further pharmaceutical logistics cost increases and potential supply disruptions.
• API and excipient buyers should review single-source supplier risks for Gulf-adjacent petrochemical-derived pharmaceutical inputs, establishing secondary supply arrangements with non-Gulf origin manufacturers in India, China, and Europe.
• Hospital pharmacy procurement managers should review cold-chain logistics contracts for temperature-sensitive ambulatory surgical centers therapeutics, ensuring that alternative air routing through non-conflict-zone hubs is available if Gulf carrier services remain suspended.

Key Market Trends and Insights

• Based on type, the treatment segment dominated the ambulatory surgical centers market with nearly 75% market share in the historical period.
• By center type, the single-specialty segment recorded the highest share of approximately 61% in the historical period.
• Based on the application, the orthopedic segment accounted for around 27% in the historical period.

Market Size and Forecast

• Market Size (2025): USD 108.67 Billion
• Projected Market Size (2035): USD 170.38 Billion
• CAGR (2026-2035): 4.60%

Ambulatory Surgical Centers Market Overview

Ambulatory surgical centers (ASCs) are dedicated healthcare facilities designed to provide patients with same-day surgical care, including diagnostic, preventive, and therapeutic procedures, without requiring an overnight hospital stay. The rising prevalence of chronic conditions continues to drive demand for outpatient surgical interventions performed in these settings. The market is projected to reach USD 170.38 Billion by 2035, growing at a CAGR of 4.60% during 2026-2035. The market has witnessed consistent expansion driven by supportive reimbursement frameworks, demographic pressures from aging populations, and a decisive structural shift toward outpatient care delivery models.

Ambulatory Surgical Centers Market Growth Drivers

Rising Chronic Disease Burden to Accelerate the Market Expansion

The increasing prevalence of chronic diseases is a major driver fueling growth in the ambulatory surgical centers market, as it significantly raises the demand for surgical interventions and outpatient procedures. Conditions such as cardiovascular diseases, diabetes, and cancer often require timely and cost-effective surgical care, making ambulatory centers a preferred option. Findings by Gabriel A. Benavidez et al. 2024, highlighted that approximately 129 million people in the United States are living with at least one chronic condition, with a growing proportion experiencing multiple comorbidities. This escalating disease burden continues to drive procedure volumes, supporting sustained market growth.

Ambulatory Surgical Centers Market Trends

The market is witnessing a trend of expanding advanced cardiac procedures in ambulatory settings.

Increasing Expansion of Advanced Cardiac Procedures in Ambulatory Settings is Poised to Enhance the Market Growth

The growing shift of complex cardiovascular procedures into ambulatory surgical centers is emerging as a key trend, driven by the need for cost efficiency and improved patient access. In May 2024, the Heart Rhythm Society, in collaboration with the American College of Cardiology, highlighted increasing clinical interest and supportive safety data for performing cardiac ablation procedures in ambulatory settings, while engaging with the Centers for Medicare & Medicaid Services for potential reimbursement inclusion. This evolving regulatory and clinical support is expected to accelerate procedural adoption, thereby driving sustained market growth.

Ambulatory Surgical Centers Market Segmentation

Market Breakup by Type

• Diagnosis
• Treatment

Market Breakup by Center Type

• Single Specialty
• Multi-Specialty

Market Breakup by Application

• Orthopedic
• Pain Management
• Gastroenterology
• Ophthalmology
• Dermatology
• Obstetrics/Gynecology
• Dental
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Ambulatory Surgical Centers Market Share

Orthopedic Application Segment Poised to Lead the Application Segment

The market is segmented by application into orthopedic, pain management, gastroenterology, ophthalmology, dermatology, obstetrics/gynecology, dental, and others. Among these, the orthopedic segment is expected to lead due to the growing global burden of musculoskeletal disorders and the increasing preference for minimally invasive surgical procedures. According to the World Health Organization (WHO), in 2019, approximately 528 million people were living with osteoarthritis, reflecting a 113% rise since 1990, with a significant proportion requiring surgical or rehabilitative care. This rising patient pool continues to drive demand, positioning orthopedic applications as the dominant segment in the coming years.

Ambulatory Surgical Centers Market Analysis by Region

The regions included in the market are North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Among these, North America is expected to hold a significant market share due to its advanced healthcare systems, high procedure volumes, and strong adoption of cost-effective outpatient surgeries. Supporting this dominance, in June 2023, St. George Surgical Center inaugurated a 13,000-square-foot state-of-the-art facility in Utah, enhancing surgical capacity and patient care efficiency. Such developments, alongside favorable reimbursement frameworks and technological integration, continue to reinforce North America’s leading position in the market.

Leading Players in the Ambulatory Surgical Centers Market

The key features of the market report comprise funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:

United Surgical Partners International

United Surgical Partners International (USPI) is a leading operator of ambulatory surgery centers and surgical hospitals across the United States, with a strong network of over 535 facilities. The company performs more than 2 million procedures annually, supported by partnerships with over 50 health systems and a large physician base. USPI focuses on delivering high-quality, patient-centered outpatient surgical care through efficient, cost-effective solutions. Its extensive collaboration model and growing footprint reinforce its significant role in advancing accessibility and operational excellence within the market.

Tenet Healthcare

Tenet Healthcare Corporation is a diversified healthcare services provider headquartered in Dallas, with a strong presence in ambulatory surgical centers through its subsidiary, United Surgical Partners International, the largest ambulatory platform in the United States. The company operates numerous outpatient surgery centers and surgical hospitals, supporting efficient, cost-effective procedures. Recent updates highlight its strong financial performance and strategic transactions, reinforcing its expansion and operational strength. Through integrated care delivery and revenue cycle solutions, Tenet continues to enhance access, efficiency, and quality within the ambulatory surgical centers market.

Regent Surgical Health

Regent Surgical Health is a leading operator and partner in ambulatory surgical center (ASC) development, focused on delivering high-quality, cost-effective outpatient surgical care. The company collaborates with prominent health systems such as Ascension, Lee Health, and RWJBarnabas Health to expand ASC networks through a system-first strategy tailored to partner needs. Regent emphasizes clinical excellence through standardized protocols and strong physician alignment, supporting over 100,000 cases annually. Its investment in digital infrastructure and informatics platforms enhances patient experience and operational efficiency, reinforcing its growing role in advancing modern outpatient surgical solutions.

Nueterra Healthcare

Nueterra Healthcare is a long-established healthcare investment and development firm founded in 1997, with a strong focus on ambulatory surgery centers (ASCs). Through its NueHealth platform, the company has developed and managed a nationwide network of approximately 150 surgery centers, supporting efficient outpatient care delivery. Its investment funds have consistently targeted ASC services, specialty hospitals, and healthcare infrastructure, while recent initiatives emphasize technology integration and value-based care models.

Other key players in the market include Envision Healthcare, Symbion, Terveystalo Healthcare Oyj, AmSurg Corp., and SCA Health.

Key Questions Answered in the Ambulatory Surgical Centers Market Report

• What was the ambulatory surgical centers market value in 2025?
• What is the ambulatory surgical centers market forecast outlook for 2026-2035?
• What major factors aid the demand for the ambulatory surgical centers market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market’s major drivers, opportunities, and restraints?
• What are the major ambulatory surgical centers market trends?
• Which type is expected to dominate the market segment?
• Which center type is projected to lead the market segment?
• Which application is anticipated to drive the market segment?
• Which region is likely to dominate the market segment?
• Who are the key players in the ambulatory surgical centers market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?